Double maintains 3 strategies that include RNA - Avidity Biosciences, Inc.
Yahoo
Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and Research, Peter Marks. RBC Capital says the development is “not good for the biotech industry even beyond vaccines.” Voicing a similar opinion, BMO Capital told investors this morning that it sees the news as a “significant negative” for the biopharma and biotech sectors. “NOT GOOD” FOR BIOTECH SECTOR: RBC Capit
Yahoo
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that Avidity management will participate in a fireside chat during the following investor conference:
Yahoo
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced the completion of enrollment in the biomarker cohort in the Phase 1/2 FORTITUDE™ clinical trial of delpacibart braxlosiran (del-brax) in people living with facioscapulohumeral muscular dystrophy (FSHD). A total of 51 participants were enrolled in the FORTITUDE biomarker cohort.
SeekingAlpha
RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with stability and specificity. Explore more details here.
SeekingAlpha
Avidity Biosciences, Inc.'s innovative AOC platform and promising clinical programs make it a high-risk, high-reward investment. Read more on RNA stock update.
Finnhub
SAN DIEGO - Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates , today announced that on March...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DYN | 46.41% | $1.18B | -62.64% | 0.00% |
ACLX | 46.16% | $3.60B | -2.06% | 0.00% |
STOK | 45.13% | $359.62M | -50.70% | 0.00% |
CRNX | 43.51% | $3.12B | -27.92% | 0.00% |
CASY | 43.49% | $16.11B | +37.63% | 0.44% |
RYTM | 42.54% | $3.35B | +24.11% | 0.00% |
RVMD | 41.43% | $6.57B | +11.62% | 0.00% |
GFF | 41.20% | $3.40B | -0.97% | 0.91% |
ROIV | 40.84% | $7.20B | -3.26% | 0.00% |
DNLI | 39.49% | $1.97B | -33.88% | 0.00% |
WD | 38.78% | $2.90B | -13.50% | 3.07% |
BLD | 38.57% | $8.92B | -30.43% | 0.00% |
RARE | 38.34% | $3.35B | -22.91% | 0.00% |
ESI | 38.11% | $5.48B | -9.52% | 1.42% |
NTLA | 37.74% | $736.01M | -73.88% | 0.00% |
RCKT | 37.73% | $711.22M | -75.04% | 0.00% |
AZEK | 37.68% | $7.02B | -0.53% | 0.00% |
SNDX | 37.68% | $1.06B | -48.34% | 0.00% |
NRIX | 37.56% | $901.54M | -18.52% | 0.00% |
ALEC | 37.29% | $121.88M | -80.03% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CF | 0.01% | $13.01B | -6.22% | 2.55% |
UFI | -0.06% | $88.27M | -17.07% | 0.00% |
LTM | 0.10% | $9.45B | -100.00% | <0.01% |
LU | -0.14% | $2.49B | -32.35% | 0.00% |
MKC | 0.19% | $22.07B | +7.43% | 2.07% |
OMCL | 0.23% | $1.63B | +22.11% | 0.00% |
VSTA | 0.25% | $363.18M | +12.97% | 0.00% |
SPTN | -0.26% | $684.07M | +2.07% | 4.31% |
CAH | 0.29% | $33.28B | +22.94% | 1.10% |
ABT | 0.32% | $230.06B | +18.34% | 1.69% |
SO | 0.36% | $100.85B | +29.32% | 3.14% |
HUSA | -0.43% | $12.08M | -45.38% | 0.00% |
HRL | 0.44% | $17.01B | -11.55% | 3.66% |
ALL | 0.48% | $54.88B | +19.99% | 1.81% |
BNED | -0.48% | $357.56M | -83.95% | 0.00% |
NTES | 0.53% | $64.06B | +4.27% | 2.45% |
HEES | 0.56% | $3.47B | +50.53% | 1.16% |
STVN | -0.58% | $5.57B | -34.82% | 0.28% |
DOLE | 0.59% | $1.37B | +22.67% | 2.23% |
DRD | 0.60% | $1.33B | +85.94% | 1.78% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ICLO | 0.04% | $354.53M | 0.2% |
TFLO | -0.14% | $6.78B | 0.15% |
FXI | 0.18% | $7.57B | 0.74% |
SHV | 0.27% | $20.11B | 0.15% |
BCD | 0.29% | $249.09M | 0.3% |
FTGC | -0.38% | $2.50B | 1.02% |
DBA | 0.39% | $822.16M | 0.93% |
GXC | 0.41% | $474.99M | 0.59% |
FLTR | 0.43% | $2.42B | 0.14% |
MCHI | 0.47% | $6.33B | 0.59% |
BCI | -0.50% | $1.43B | 0.26% |
OILK | -0.57% | $66.42M | 0.69% |
ULST | 0.75% | $587.03M | 0.2% |
FMF | 0.77% | $154.69M | 0.95% |
MINT | 0.86% | $13.27B | 0.35% |
FLCH | 0.93% | $176.63M | 0.19% |
USFR | -0.95% | $18.41B | 0.15% |
DBO | -1.05% | $197.54M | 0.77% |
BNO | -1.09% | $95.40M | 1% |
IBMN | 1.14% | $473.20M | 0.18% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -32.62% | $404.97M | 1.43% |
VIXY | -29.56% | $195.31M | 0.85% |
TAIL | -22.17% | $86.92M | 0.59% |
TPMN | -16.13% | $33.51M | 0.65% |
CTA | -15.32% | $963.19M | 0.76% |
KMLM | -8.52% | $222.40M | 0.9% |
SGOV | -7.64% | $39.39B | 0.09% |
XHLF | -7.35% | $1.06B | 0.03% |
UUP | -6.91% | $327.80M | 0.77% |
USDU | -6.41% | $213.46M | 0.5% |
GBIL | -5.95% | $6.31B | 0.12% |
VRIG | -5.75% | $1.44B | 0.3% |
UNG | -5.67% | $434.44M | 1.06% |
WEAT | -5.16% | $113.78M | 0.28% |
KRBN | -4.87% | $173.49M | 0.85% |
DBE | -4.18% | $54.58M | 0.77% |
USCI | -4.14% | $236.09M | 1.07% |
FXY | -3.59% | $546.19M | 0.4% |
CORN | -3.54% | $51.34M | 0.2% |
TBIL | -3.42% | $5.32B | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 54.37% | $53.29M | 0.5% |
XBI | 53.94% | $5.33B | 0.35% |
PTH | 51.83% | $110.42M | 0.6% |
IBB | 49.84% | $5.92B | 0.45% |
IWO | 43.48% | $10.88B | 0.24% |
PBE | 43.35% | $233.11M | 0.58% |
TMSL | 42.83% | $654.90M | 0.55% |
CPSJ | 42.81% | $32.78M | 0.69% |
ISCG | 42.75% | $654.50M | 0.06% |
ARKG | 42.66% | $977.87M | 0.75% |
NUSC | 42.51% | $1.11B | 0.31% |
CPRJ | 42.32% | $48.46M | 0.69% |
KJUL | 42.25% | $155.38M | 0.79% |
BBH | 42.12% | $368.79M | 0.35% |
SCHA | 41.99% | $15.95B | 0.04% |
VTWO | 41.90% | $10.91B | 0.07% |
IWC | 41.89% | $810.14M | 0.6% |
IWM | 41.85% | $64.21B | 0.19% |
VBK | 41.55% | $17.51B | 0.07% |
ESML | 41.33% | $1.76B | 0.17% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -25.64% | $23.69B | +24.42% | 1.08% |
LITB | -12.37% | $36.77M | -56.14% | 0.00% |
EXC | -11.48% | $46.52B | +23.77% | 3.35% |
CLX | -10.43% | $18.14B | -2.90% | 3.29% |
MDLZ | -10.16% | $87.77B | -2.74% | 2.69% |
LMT | -9.44% | $105.15B | -1.34% | 2.88% |
COR | -9.20% | $53.93B | +14.44% | 0.76% |
VZ | -8.19% | $190.95B | +7.28% | 5.89% |
CME | -7.66% | $95.61B | +25.13% | 3.98% |
NEUE | -7.58% | $58.51M | +7.28% | 0.00% |
CHD | -7.58% | $27.09B | +4.83% | 1.03% |
CYCN | -7.53% | $6.78M | -18.57% | 0.00% |
GIS | -7.43% | $32.74B | -14.74% | 3.99% |
BG | -7.32% | $10.24B | -25.29% | 3.53% |
PG | -6.80% | $399.61B | +6.13% | 2.36% |
PSQH | -6.16% | $98.27M | -53.36% | 0.00% |
SRRK | -6.07% | $3.04B | +91.48% | 0.00% |
D | -5.90% | $47.77B | +14.06% | 4.77% |
NOC | -5.27% | $74.12B | +8.63% | 1.60% |
K | -5.22% | $28.48B | +44.57% | 2.75% |
Current Value
$29.361 Year Return
Current Value
$29.361 Year Return